BIOCRYST PHARMACEUTICALS, INC. Restructuring Charges
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Restructuring Charges of -$97.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2015-03-02
- BIOCRYST PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2012-12-31 was $1.76M.
- BIOCRYST PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2010-12-31 was $302.00K.
- BIOCRYST PHARMACEUTICALS, INC. restructuring charges for fiscal 2013 was -$97.00K, a 105.51% decline from fiscal 2012.
- BIOCRYST PHARMACEUTICALS, INC. restructuring charges for fiscal 2012 was $1.76M.
- BIOCRYST PHARMACEUTICALS, INC. restructuring charges for fiscal 2010 was $1.03M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 12 month |
|---|---|---|
| 2013-12-31 | -$97.00K 10-K · filed 2015-03-02 | |
| 2012-12-31 | $1.76M 10-Q · filed 2013-11-08 | $1.76M 10-K · filed 2015-03-02 |
| 2010-12-31 | $302.00K 10-K · filed 2013-03-11 | $1.03M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |